{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:48:04Z","timestamp":1782859684171,"version":"3.54.5"},"reference-count":261,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tuberculosis (TB), a disease caused by\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    , remains one of the major causes of death from infection worldwide, with over a million associated deaths each year. The study of biomarkers for TB is critical for advancing our understanding and management of the disease. Biomarkers, defined as measurable indicators of biological states or conditions, are invaluable for the diagnosis, prognosis and treatment monitoring of TB. Clinical studies have provided critical knowledge on the matter but are also notoriously constrained by economical, ethical and sampling limitations. The use of animal models provides a simpler, more controllable, cost-effective setting with great potential for translation to humans. They also allow the evaluation of biomarkers within the respiratory compartment, when available, which is of particular interest due to the nature of TB pathogenesis. This Review focuses on the current landscape of TB biomarker discovery in several animal models, from invertebrates to large mammals. Here we summarize the basics of host\u2013pathogen immune interaction, describe the main methodological approaches used and highlight the most substantial findings for each animal model studied. Furthermore, we discuss the advantages, challenges and limitations associated with species-specific differences in animal models. We conclude that integrating the data obtained from animal models and human studies is absolutely required to advance the TB field to accelerate the management of this disease.\n                  <\/jats:p>","DOI":"10.1038\/s41684-026-01730-9","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:02:15Z","timestamp":1780563735000},"page":"248-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The study of immunological markers in tuberculosis across animal models and its translation to human research"],"prefix":"10.1038","volume":"55","author":[{"given":"Sergio","family":"D\u00edaz-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Aleluia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Soldevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi B.","family":"Torrelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riti","family":"Sharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A. W.","family":"Verreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2705-9873","authenticated-orcid":false,"given":"Maria","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-9182","authenticated-orcid":false,"given":"Bernat","family":"P\u00e9rez de Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jose","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalina","family":"Preda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3010-1609","authenticated-orcid":false,"given":"Eduard","family":"Torrents","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-3978","authenticated-orcid":false,"given":"Esther","family":"Juli\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8159-2455","authenticated-orcid":false,"given":"Irene","family":"Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"1730_CR1","unstructured":"Global Tuberculosis Report 2024 (WHO, 2024)."},{"key":"1730_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14760584.2019.1552140","volume":"18","author":"I Satti","year":"2019","unstructured":"Satti, I. & McShane, H. Current approaches toward identifying a correlate of immune protection from tuberculosis. Expert Rev. Vaccines 18, 43\u201359 (2019).","journal-title":"Expert Rev. Vaccines"},{"key":"1730_CR3","unstructured":"World Health Organization & International Programme on Chemical Safety Biomarkers in Risk Assessment: Validity and Validation (WHO, 2021); https:\/\/iris.who.int\/handle\/10665\/42363"},{"key":"1730_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu, K. & Tavel, J. A. What are biomarkers? Curr. Opin. HIV AIDS 5, 463\u2013466 (2010).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"1730_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf, R. M. Biomarker definitions and their applications. Exp. Biol. Med. 243, 213\u2013221 (2018).","journal-title":"Exp. Biol. Med."},{"key":"1730_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijid.2017.01.025","volume":"56","author":"S Yerlikaya","year":"2017","unstructured":"Yerlikaya, S., Broger, T., MacLean, E., Pai, M. & Denkinger, C. M. A tuberculosis biomarker database: the key to novel TB diagnostics. Int. J. Infect. Dis. 56, 253\u2013257 (2017).","journal-title":"Int. J. Infect. Dis."},{"key":"1730_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/4263079","volume":"2020","author":"W Gong","year":"2020","unstructured":"Gong, W., Liang, Y. & Wu, X. Animal models of tuberculosis vaccine research: an important component in the fight against tuberculosis. Biomed Res. Int. 2020, 1\u201321 (2020).","journal-title":"Biomed Res. Int."},{"key":"1730_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5588\/ijtld.21.0753","volume":"26","author":"GB Migliori","year":"2022","unstructured":"Migliori, G. B. et al. Clinical standards for the diagnosis, treatment and prevention of TB infection. Int. J. Tuberc. Lung Dis. 26, 190\u2013205 (2022).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"1730_CR9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230859","volume":"220","author":"BR Bloom","year":"2023","unstructured":"Bloom, B. R. A half-century of research on tuberculosis: successes and challenges. J. Exp. Med. 220, e20230859 (2023).","journal-title":"J. Exp. Med."},{"key":"1730_CR10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","volume":"20","author":"P Chandra","year":"2022","unstructured":"Chandra, P., Grigsby, S. J. & Philips, J. A. Immune evasion and provocation by Mycobacterium tuberculosis. Nat. Rev. Microbiol. 20, 750\u2013766 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"1730_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136222","volume":"131","author":"WH Boom","year":"2021","unstructured":"Boom, W. H., Schaible, U. E. & Achkar, J. M. The knowns and unknowns of latent Mycobacterium tuberculosis infection. J. Clin. Invest. 131, e136222 (2021).","journal-title":"J. Clin. Invest."},{"key":"1730_CR12","doi-asserted-by":"publisher","first-page":"1260859","DOI":"10.3389\/fimmu.2023.1260859","volume":"14","author":"P Sankar","year":"2023","unstructured":"Sankar, P. & Mishra, B. B. Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis. Front. Immunol. 14, 1260859 (2023).","journal-title":"Front. Immunol."},{"key":"1730_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.imlet.2020.02.010","volume":"221","author":"B Corleis","year":"2020","unstructured":"Corleis, B. & Dorhoi, A. Early dynamics of innate immunity during pulmonary tuberculosis. Immunol. Lett. 221, 56\u201360 (2020).","journal-title":"Immunol. Lett."},{"key":"1730_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1164\/rccm.201203-0444OC","volume":"186","author":"KP Fennelly","year":"2012","unstructured":"Fennelly, K. P. et al. Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 186, 450\u2013457 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1730_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.tim.2017.03.007","volume":"25","author":"JB Torrelles","year":"2017","unstructured":"Torrelles, J. B. & Schlesinger, L. S. Integrating lung physiology, immunology, and tuberculosis. Trends Microbiol. 25, 688\u2013697 (2017).","journal-title":"Trends Microbiol."},{"key":"1730_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw6693","volume":"4","author":"AC Rothchild","year":"2019","unstructured":"Rothchild, A. C. et al. Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo. Sci. Immunol. 4, eaaw6693 (2019).","journal-title":"Sci. Immunol."},{"key":"1730_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.chom.2018.08.001","volume":"24","author":"SB Cohen","year":"2018","unstructured":"Cohen, S. B. et al. Alveolar macrophages provide an early Mycobacterium tuberculosis niche and initiate dissemination. Cell Host Microbe 24, 439 (2018).","journal-title":"Cell Host Microbe"},{"key":"1730_CR18","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20172020","volume":"215","author":"L Huang","year":"2018","unstructured":"Huang, L., Nazarova, E. V., Tan, S., Liu, Y. & Russell, D. G. Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. J. Exp. Med. 215, 1135\u20131152 (2018).","journal-title":"J. Exp. Med."},{"key":"1730_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.celrep.2019.12.033","volume":"30","author":"D Pisu","year":"2020","unstructured":"Pisu, D., Huang, L., Grenier, J. K. & Russell, D. G. Dual RNA-seq of Mtb-infected macrophages in vivo reveals ontologically distinct host\u2013pathogen interactions. Cell Rep. 30, 335\u2013350 (2020).","journal-title":"Cell Rep."},{"key":"1730_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/thoraxjnl-2021-217997","volume":"77","author":"AM de Waal","year":"2022","unstructured":"de Waal, A. M., Hiemstra, P. S., Ottenhoff, T. H., Joosten, S. A. & van der Does, A. M. Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis. Thorax 77, 408\u2013416 (2022).","journal-title":"Thorax"},{"key":"1730_CR21","doi-asserted-by":"publisher","first-page":"1528074","DOI":"10.3389\/fimmu.2025.1528074","volume":"16","author":"AP Santos","year":"2025","unstructured":"Santos, A. P. et al. The role of neutrophil response in lung damage and post-tuberculosis lung disease: a translational narrative review. Front. Immunol. 16, 1528074 (2025).","journal-title":"Front. Immunol."},{"key":"1730_CR22","doi-asserted-by":"publisher","first-page":"10.1128","DOI":"10.1128\/microbiolspec.GPP3-0022-2018","volume":"7","author":"JK Sia","year":"2019","unstructured":"Sia, J. K. & Rengarajan, J. Immunology of Mycobacterium tuberculosis Infections. Microbiol. Spectr. 7, 10.1128 (2019).","journal-title":"Microbiol. Spectr."},{"key":"1730_CR23","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3389\/fimmu.2017.01948","volume":"8","author":"HN Bastos","year":"2017","unstructured":"Bastos, H. N., Os\u00f3rio, N. S., Gagneux, S., Comas, I. & Saraiva, M. The troika host\u2013pathogen-extrinsic factors in tuberculosis: modulating inflammation and clinical outcomes. Front. Immunol. 8, 1948 (2017).","journal-title":"Front. Immunol."},{"key":"1730_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15832-6","volume":"11","author":"J Sousa","year":"2020","unstructured":"Sousa, J. et al. Mycobacterium tuberculosis associated with severe tuberculosis evades cytosolic surveillance systems and modulates IL-1\u03b2 production. Nat. Commun. 11, 1949 (2020).","journal-title":"Nat. Commun."},{"key":"1730_CR25","doi-asserted-by":"publisher","first-page":"102365","DOI":"10.1016\/j.coi.2023.102365","volume":"84","author":"KD Mayer-Barber","year":"2023","unstructured":"Mayer-Barber, K. D. Granulocytes subsets and their divergent functions in host resistance to Mycobacterium tuberculosis\u2014a \u2018tipping-point\u2019 model of disease exacerbation. Curr. Opin. Immunol. 84, 102365 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"1730_CR26","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.3390\/ijms22094801","volume":"22","author":"RR Borkute","year":"2021","unstructured":"Borkute, R. R., Woelke, S., Pei, G. & Dorhoi, A. Neutrophils in tuberculosis: cell biology, cellular networking and multitasking in host defense. Int. J. Mol. Sci. 22, 4801 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1730_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MPR Berry","year":"2010","unstructured":"Berry, M. P. R. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973\u2013977 (2010).","journal-title":"Nature"},{"key":"1730_CR28","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane, J. et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345, 1098\u20131104 (2001).","journal-title":"N. Engl. J. Med."},{"key":"1730_CR29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.cell.2010.02.013","volume":"140","author":"DM Tobin","year":"2010","unstructured":"Tobin, D. M. et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140, 717\u2013730 (2010).","journal-title":"Cell"},{"key":"1730_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"KD Mayer-Barber","year":"2014","unstructured":"Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99\u2013103 (2014).","journal-title":"Nature"},{"key":"1730_CR31","doi-asserted-by":"publisher","first-page":"10961","DOI":"10.1073\/pnas.0801496105","volume":"105","author":"WW Reiley","year":"2008","unstructured":"Reiley, W. W. et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc. Natl Acad. Sci. USA 105, 10961\u201310966 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1730_CR32","doi-asserted-by":"publisher","first-page":"820134","DOI":"10.3389\/fimmu.2022.820134","volume":"13","author":"MR Cronan","year":"2022","unstructured":"Cronan, M. R. In the thick of it: formation of the tuberculous granuloma and its effects on host and therapeutic responses. Front. Immunol. 13, 820134 (2022).","journal-title":"Front. Immunol."},{"key":"1730_CR33","doi-asserted-by":"publisher","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","volume":"8","author":"A Pawlowski","year":"2012","unstructured":"Pawlowski, A., Jansson, M., Sk\u00f6ld, M., Rottenberg, M. E. & K\u00e4llenius, G. Tuberculosis and HIV co-infection. PLoS Pathog. 8, e1002464 (2012).","journal-title":"PLoS Pathog."},{"key":"1730_CR34","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1097\/QAD.0000000000000802","volume":"29","author":"RK Gupta","year":"2015","unstructured":"Gupta, R. K., Lucas, S. B., Fielding, K. L. & Lawn, S. D. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS 29, 1987\u20132002 (2015).","journal-title":"AIDS"},{"key":"1730_CR35","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1128\/IAI.74.4.2128-2137.2006","volume":"74","author":"L Majlessi","year":"2006","unstructured":"Majlessi, L. et al. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect. Immun. 74, 2128\u20132137 (2006).","journal-title":"Infect. Immun."},{"key":"1730_CR36","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","volume":"182","author":"BMN Kagina","year":"2010","unstructured":"Kagina, B. M. N. et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette\u2013Gu\u00e9rin vaccination of newborns. Am. J. Respir. Crit. Care Med. 182, 1073\u20131079 (2010).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1730_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20930-0","volume":"12","author":"A Watson","year":"2021","unstructured":"Watson, A. et al. Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis. Nat. Commun. 12, 602 (2021).","journal-title":"Nat. Commun."},{"key":"1730_CR38","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/s41590-021-01066-1","volume":"22","author":"EB Irvine","year":"2021","unstructured":"Irvine, E. B. et al. Robust IgM responses following intravenous vaccination with Bacille Calmette\u2013Gu\u00e9rin associate with prevention of Mycobacterium tuberculosis infection in macaques. Nat. Immunol. 22, 1515\u20131523 (2021).","journal-title":"Nat. Immunol."},{"key":"1730_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","volume":"167","author":"LL Lu","year":"2016","unstructured":"Lu, L. L. et al. A functional role for antibodies in tuberculosis. Cell 167, 433\u2013443 (2016).","journal-title":"Cell"},{"key":"1730_CR40","doi-asserted-by":"publisher","first-page":"679973","DOI":"10.3389\/fimmu.2021.679973","volume":"12","author":"PS Grace","year":"2021","unstructured":"Grace, P. S. et al. Antibody subclass and glycosylation shift following effective TB treatment. Front. Immunol. 12, 679973 (2021).","journal-title":"Front. Immunol."},{"key":"1730_CR41","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/s41591-019-0441-3","volume":"25","author":"LL Lu","year":"2019","unstructured":"Lu, L. L. et al. IFN-\u03b3-independent immune markers of Mycobacterium tuberculosis exposure. Nat. Med. 25, 977\u2013987 (2019).","journal-title":"Nat. Med."},{"key":"1730_CR42","unstructured":"Latent Tuberculosis Infection Updated and Consolidated Guidelines for Programmatic Management (Global Tuberculosis Programme, 2018)."},{"key":"1730_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102332","volume":"66","author":"SMA Zaidi","year":"2023","unstructured":"Zaidi, S. M. A. et al. Beyond latent and active tuberculosis: a scoping review of conceptual frameworks. eClinicalMedicine 66, 102332 (2023).","journal-title":"eClinicalMedicine"},{"key":"1730_CR44","first-page":"204993612210958","volume":"9","author":"G C\u00e1ceres","year":"2022","unstructured":"C\u00e1ceres, G., Calderon, R. & Ugarte-Gil, C. Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression. Ther. Adv. Infect. Dis. 9, 20499361221095830 (2022).","journal-title":"Ther. Adv. Infect. Dis."},{"key":"1730_CR45","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114088","volume":"14","author":"BMF Nogueira","year":"2022","unstructured":"Nogueira, B. M. F. et al. Diagnostic biomarkers for active tuberculosis: progress and challenges. EMBO Mol. Med. 14, e14088 (2022).","journal-title":"EMBO Mol. Med."},{"key":"1730_CR46","unstructured":"Mirzayev, F., Nguyen, L., Gegia, M. & Viney, K. WHO Operational Handbook on Tuberculosis. Module 4: Treatment\u2014Drug-resistant Tuberculosis Treatment, 2022 Update (WHO, 2020)."},{"key":"1730_CR47","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01859-21","volume":"60","author":"AJ Zimmer","year":"2022","unstructured":"Zimmer, A. J. et al. Biomarkers that correlate with active pulmonary tuberculosis treatment response: a systematic review and meta-analysis. J. Clin. Microbiol. 60, e0185921 (2022).","journal-title":"J. Clin. Microbiol."},{"key":"1730_CR48","doi-asserted-by":"publisher","first-page":"640916","DOI":"10.3389\/fimmu.2021.640916","volume":"12","author":"H Morrison","year":"2021","unstructured":"Morrison, H. & McShane, H. Local pulmonary immunological biomarkers in tuberculosis. Front. Immunol. 12, 640916 (2021).","journal-title":"Front. Immunol."},{"key":"1730_CR49","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1126\/science.287.5461.2204","volume":"287","author":"GM Rubin","year":"2000","unstructured":"Rubin, G. M. et al. Comparative genomics of the eukaryotes. Science 287, 2204\u20132215 (2000).","journal-title":"Science"},{"key":"1730_CR50","doi-asserted-by":"publisher","first-page":"905370","DOI":"10.3389\/fimmu.2022.905370","volume":"13","author":"S Yu","year":"2022","unstructured":"Yu, S., Luo, F., Xu, Y., Zhang, Y. & Jin, L. H. Drosophila innate immunity involves multiple signaling pathways and coordinated communication between different tissues. Front. Immunol. 13, 905370 (2022).","journal-title":"Front. Immunol."},{"key":"1730_CR51","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nri3763","volume":"14","author":"N Buchon","year":"2014","unstructured":"Buchon, N., Silverman, N. & Cherry, S. Immunity in Drosophila melanogaster\u2014from microbial recognition to whole-organism physiology. Nat. Rev. Immunol. 14, 796\u2013810 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"1730_CR52","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.cub.2006.08.052","volume":"16","author":"MS Dionne","year":"2006","unstructured":"Dionne, M. S., Pham, L. N., Shirasu-Hiza, M. & Schneider, D. S. Akt and FOXO dysregulation contribute to infection-induced wasting in Drosophila. Curr. Biol. 16, 1977\u20131985 (2006).","journal-title":"Curr. Biol."},{"key":"1730_CR53","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/emph\/eoad029","volume":"11","author":"M Arch","year":"2023","unstructured":"Arch, M., Vidal, M., Fuentes, E., Abat, A. S. & Cardona, P. J. The reproductive status determines tolerance and resistance to Mycobacterium marinum in Drosophila melanogaster. Evol. Med. Public Health 11, 332\u2013347 (2023).","journal-title":"Evol. Med. Public Health"},{"key":"1730_CR54","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1128\/IAI.71.6.3540-3550.2003","volume":"71","author":"MS Dionne","year":"2003","unstructured":"Dionne, M. S., Ghori, N. & Schneider, D. S. Drosophila melanogaster is a genetically tractable model host for Mycobacterium marinum. Infect. Immun. 71, 3540\u20133550 (2003).","journal-title":"Infect. Immun."},{"key":"1730_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14642","volume":"8","author":"CB Pe\u00e1n","year":"2017","unstructured":"Pe\u00e1n, C. B. et al. Regulation of phagocyte triglyceride by a STAT\u2013ATG2 pathway controls mycobacterial infection. Nat. Commun. 8, 14642 (2017).","journal-title":"Nat. Commun."},{"key":"1730_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03477-3","volume":"7","author":"TS Kim","year":"2017","unstructured":"Kim, T. S. et al. Ohmyungsamycins promote antimicrobial responses through autophagy activation via AMP-activated protein kinase pathway. Sci. Rep. 7, 3431 (2017).","journal-title":"Sci. Rep."},{"key":"1730_CR57","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/mmi.14819","volume":"117","author":"EKP Marshall","year":"2022","unstructured":"Marshall, E. K. P. & Dionne, M. S. Drosophila versus Mycobacteria: a model for mycobacterial host-pathogen interactions. Mol. Microbiol. 117, 600\u2013609 (2022).","journal-title":"Mol. Microbiol."},{"key":"1730_CR58","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/21505594.2015.1135289","volume":"7","author":"CJY Tsai","year":"2016","unstructured":"Tsai, C. J. Y., Loh, J. M. S. & Proft, T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence 7, 214\u2013229 (2016).","journal-title":"Virulence"},{"key":"1730_CR59","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1080\/21505594.2022.2119657","volume":"13","author":"M Asai","year":"2022","unstructured":"Asai, M. et al. Galleria mellonella as an infection model for the virulent Mycobacterium tuberculosis H37Rv. Virulence 13, 1543\u20131557 (2022).","journal-title":"Virulence"},{"key":"1730_CR60","doi-asserted-by":"publisher","first-page":"107975","DOI":"10.1016\/j.jip.2023.107975","volume":"200","author":"J Admella","year":"2023","unstructured":"Admella, J. & Torrents, E. Investigating bacterial infections in Galleria mellonella larvae: Insights into pathogen dissemination and behavior. J. Invertebr. Pathol. 200, 107975 (2023).","journal-title":"J. Invertebr. Pathol."},{"key":"1730_CR61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1099\/jmm.0.000696","volume":"67","author":"FM Entwistle","year":"2018","unstructured":"Entwistle, F. M. & Coote, P. J. Evaluation of greater wax moth larvae, Galleria mellonella, as a novel in vivo model for non-tuberculosis mycobacteria infections and antibiotic treatments. J. Med. Microbiol. 67, 585\u2013597 (2018).","journal-title":"J. Med. Microbiol."},{"key":"1730_CR62","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02539-17","volume":"62","author":"M Meir","year":"2018","unstructured":"Meir, M., Grosfeld, T. & Barkan, D. Establishment and validation of Galleria mellonella as a novel model organism to study Mycobacterium abscessus infection, pathogenesis, and treatment. Antimicrob. Agents Chemother. 62, e02539 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1730_CR63","doi-asserted-by":"publisher","first-page":"2493221","DOI":"10.1080\/21505594.2025.2493221","volume":"16","author":"V Campo-P\u00e9rez","year":"2025","unstructured":"Campo-P\u00e9rez, V., Juli\u00e1n, E. & Torrents, E. Interplay of Mycobacterium abscessus and Pseudomonas aeruginosa in experimental models of coinfection: biofilm dynamics and host immune response. Virulence 16, 2493221 (2025).","journal-title":"Virulence"},{"key":"1730_CR64","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/vaccines8020198","volume":"8","author":"M Bach-Griera","year":"2020","unstructured":"Bach-Griera, M. et al. Mycolicibacterium brumae is a safe and non-toxic immunomodulatory agent for cancer treatment. Vaccines 8, 198 (2020).","journal-title":"Vaccines"},{"key":"1730_CR65","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1080\/21505594.2018.1491255","volume":"9","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Galleria mellonella\u2014a novel infection model for the Mycobacterium tuberculosis complex. Virulence 9, 1126\u20131137 (2018).","journal-title":"Virulence"},{"key":"1730_CR66","doi-asserted-by":"publisher","first-page":"487231","DOI":"10.3389\/fmicb.2019.02630","volume":"10","author":"M Asai","year":"2019","unstructured":"Asai, M. et al. Galleria mellonella: an infection model for screening compounds against the Mycobacterium tuberculosis complex. Front. Microbiol. 10, 487231 (2019).","journal-title":"Front. Microbiol."},{"key":"1730_CR67","doi-asserted-by":"publisher","first-page":"619981","DOI":"10.3389\/fcimb.2021.619981","volume":"11","author":"M Asai","year":"2021","unstructured":"Asai, M. et al. Innate immune responses of Galleria mellonella to Mycobacterium bovis BCG challenge identified using proteomic and molecular approaches. Front. Cell. Infect. Microbiol. 11, 619981 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1730_CR68","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.tim.2023.11.011","volume":"32","author":"MD Johansen","year":"2024","unstructured":"Johansen, M. D., Spaink, H. P., Oehlers, S. H. & Kremer, L. Modeling nontuberculous mycobacterial infections in zebrafish. Trends Microbiol. 32, 663\u2013677 (2024).","journal-title":"Trends Microbiol."},{"key":"1730_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.dci.2012.04.001","volume":"39","author":"LY Zhu","year":"2013","unstructured":"Zhu, L. Y., Nie, L., Zhu, G., Xiang, L. X. & Shao, J. Z. Advances in research of fish immune-relevant genes: a comparative overview of innate and adaptive immunity in teleosts. Dev. Comp. Immunol. 39, 39\u201362 (2013).","journal-title":"Dev. Comp. Immunol."},{"key":"1730_CR70","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.dci.2007.11.011","volume":"32","author":"ND Meeker","year":"2008","unstructured":"Meeker, N. D. & Trede, N. S. Immunology and zebrafish: spawning new models of human disease. Dev. Comp. Immunol. 32, 745\u2013757 (2008).","journal-title":"Dev. Comp. Immunol."},{"key":"1730_CR71","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nprot.2013.068","volume":"8","author":"K Takaki","year":"2013","unstructured":"Takaki, K., Davis, J. M., Winglee, K. & Ramakrishnan, L. Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish. Nat. Protoc. 8, 1114\u20131124 (2013).","journal-title":"Nat. Protoc."},{"key":"1730_CR72","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1074-7613(02)00475-2","volume":"17","author":"JM Davis","year":"2002","unstructured":"Davis, J. M. et al. Real-time visualization of mycobacterium\u2013macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17, 693\u2013702 (2002).","journal-title":"Immunity"},{"key":"1730_CR73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2008.11.014","volume":"136","author":"JM Davis","year":"2009","unstructured":"Davis, J. M. & Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37\u201349 (2009).","journal-title":"Cell"},{"key":"1730_CR74","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1164\/ajrccm.162.3.9911010","volume":"162","author":"W Matsuyama","year":"2000","unstructured":"Matsuyama, W. et al. Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 162, 1120\u20131122 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1730_CR75","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature13967","volume":"517","author":"SH Oehlers","year":"2015","unstructured":"Oehlers, S. H. et al. Interception of host angiogenic signalling limits mycobacterial growth. Nature 517, 612\u2013615 (2015).","journal-title":"Nature"},{"key":"1730_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-6265-1","volume":"20","author":"W Hu","year":"2019","unstructured":"Hu, W. et al. Infection and RNA-seq analysis of a zebrafish tlr2 mutant shows a broad function of this toll-like receptor in transcriptional and metabolic control and defense to Mycobacterium marinum infection. BMC Genomics 20, 878 (2019).","journal-title":"BMC Genomics"},{"key":"1730_CR77","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2322663","volume":"13","author":"H Su","year":"2024","unstructured":"Su, H. et al. Mycobacterium tuberculosis hijacks host macrophages-derived interleukin 16 to block phagolysosome maturation for enhancing intracellular growth. Emerg. Microbes Infect. 13, 2322663 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"1730_CR78","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3389\/fimmu.2019.00832","volume":"10","author":"J Rougeot","year":"2019","unstructured":"Rougeot, J. et al. RNAseq profiling of leukocyte populations in zebrafish larvae reveals a cxcl11 chemokine gene as a marker of macrophage polarization during mycobacterial infection. Front. Immunol. 10, 832 (2019).","journal-title":"Front. Immunol."},{"key":"1730_CR79","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/j.1462-5822.2012.01755.x","volume":"14","author":"EM Weerdenburg","year":"2012","unstructured":"Weerdenburg, E. M. et al. ESX-5-deficient Mycobacterium marinum is hypervirulent in adult zebrafish. Cell. Microbiol. 14, 728\u2013739 (2012).","journal-title":"Cell. Microbiol."},{"key":"1730_CR80","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1016\/j.celrep.2016.07.080","volume":"16","author":"Z Chen","year":"2016","unstructured":"Chen, Z. et al. Mycobacterial WhiB6 differentially regulates ESX-1 and the Dos Regulon to modulate granuloma formation and virulence in zebrafish. Cell Rep. 16, 2512\u20132524 (2016).","journal-title":"Cell Rep."},{"key":"1730_CR81","doi-asserted-by":"publisher","first-page":"208965","DOI":"10.3389\/fmicb.2016.01347","volume":"7","author":"MH Vemula","year":"2016","unstructured":"Vemula, M. H. et al. Mycobacterium tuberculosis zinc metalloprotease-1 assists mycobacterial dissemination in zebrafish. Front. Microbiol. 7, 208965 (2016).","journal-title":"Front. Microbiol."},{"key":"1730_CR82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fcimb.2020.00065","volume":"10","author":"MG Moule","year":"2020","unstructured":"Moule, M. G. & Cirillo, J. D. Mycobacterium tuberculosis dissemination plays a critical role in pathogenesis. Front. Cell. Infect. Microbiol. 10, 65 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1730_CR83","doi-asserted-by":"publisher","first-page":"a018556","DOI":"10.1101\/cshperspect.a018556","volume":"5","author":"AM Cooper","year":"2015","unstructured":"Cooper, A. M. Mouse model of tuberculosis. Cold Spring Harb. Perspect. Med. 5, a018556\u2013a018556 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1730_CR84","doi-asserted-by":"publisher","unstructured":"Kramnik, I., Demant, P. & Bloom, B. B. in Genetics and Tuberculosis (eds Chadwick, D. J. & Cardew, G.) 120\u2013137 (Wiley, 1998); https:\/\/doi.org\/10.1002\/0470846526.ch9","DOI":"10.1002\/0470846526.ch9"},{"key":"1730_CR85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-9086-3_1","volume":"1940","author":"K Rydell-T\u00f6rm\u00e4nen","year":"2019","unstructured":"Rydell-T\u00f6rm\u00e4nen, K. & Johnson, J. R. The applicability of mouse models to the study of human disease. Methods Mol. Biol. 1940, 3\u201322 (2019).","journal-title":"Methods Mol. Biol."},{"key":"1730_CR86","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/pathogens12010049","volume":"12","author":"P Soldevilla","year":"2022","unstructured":"Soldevilla, P., Vilaplana, C. & Cardona, P. J. Mouse models for Mycobacterium tuberculosis pathogenesis: show and do not tell. Pathogens 12, 49 (2022).","journal-title":"Pathogens"},{"key":"1730_CR87","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1086\/599092","volume":"199","author":"Y Jung","year":"2009","unstructured":"Jung, Y., Ryan, L., LaCourse, R. & North, R. J. Differences in the ability to generate type 1 T helper cells need not determine differences in the ability to resist Mycobacterium tuberculosis infection among mouse strains. J. Infect. Dis. 199, 1790\u20131796 (2009).","journal-title":"J. Infect. Dis."},{"key":"1730_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-81446-3","volume":"15","author":"MaF Arce-Aceves","year":"2025","unstructured":"Arce-Aceves, M.a F. et al. Fitness costs of Mycobacterium tuberculosis resistant to rifampicin is compensated by rapid Th2 polarization mediated by early and high IL-4 production during mice infection. Sci. Rep. 15, 2811 (2025).","journal-title":"Sci. Rep."},{"key":"1730_CR89","doi-asserted-by":"publisher","first-page":"8560","DOI":"10.1073\/pnas.150227197","volume":"97","author":"I Kramnik","year":"2000","unstructured":"Kramnik, I., Dietrich, W. F., Demant, P. & Bloom, B. R. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 97, 8560\u20138565 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1730_CR90","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tube.2013.09.004","volume":"94","author":"E Marzo","year":"2014","unstructured":"Marzo, E. et al. Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis. Tuberculosis 94, 55\u201364 (2014).","journal-title":"Tuberculosis"},{"key":"1730_CR91","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.vaccine.2004.11.032","volume":"23","author":"A Rodr\u00edguez","year":"2005","unstructured":"Rodr\u00edguez, A. et al. Role of IgA in the defense against respiratory infections: IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. Vaccine 23, 2565\u20132572 (2005).","journal-title":"Vaccine"},{"key":"1730_CR92","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/intimm\/dxl017","volume":"18","author":"A Tj\u00e4rnlund","year":"2006","unstructured":"Tj\u00e4rnlund, A. et al. Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice. Int. Immunol. 18, 807\u2013816 (2006).","journal-title":"Int. Immunol."},{"key":"1730_CR93","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/mi.2011.7","volume":"4","author":"PS Redford","year":"2011","unstructured":"Redford, P. S., Murray, P. J. & O\u2019Garra, A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 4, 261\u2013270 (2011).","journal-title":"Mucosal Immunol."},{"key":"1730_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009773","volume":"17","author":"D Koyuncu","year":"2021","unstructured":"Koyuncu, D. et al. CXCL1: A new diagnostic biomarker for human tuberculosis discovered using Diversity Outbred mice. PLoS Pathog. 17, e1009773 (2021).","journal-title":"PLoS Pathog."},{"key":"1730_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19412-6","volume":"11","author":"L Moreira-Teixeira","year":"2020","unstructured":"Moreira-Teixeira, L. et al. Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nat. Commun. 11, 5566 (2020).","journal-title":"Nat. Commun."},{"key":"1730_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73942-z","volume":"10","author":"RC Ault","year":"2020","unstructured":"Ault, R. C. et al. Blood RNA signatures predict recent tuberculosis exposure in mice, macaques and humans. Sci. Rep. 10, 16873 (2020).","journal-title":"Sci. Rep."},{"key":"1730_CR97","doi-asserted-by":"publisher","first-page":"e0289358","DOI":"10.1371\/journal.pone.0289358","volume":"18","author":"SL Kurtz","year":"2023","unstructured":"Kurtz, S. L., Ryd\u00e9n, P. & Elkins, K. L. Transcriptional signatures measured in whole blood correlate with protection against tuberculosis in inbred and outbred mice. PLoS ONE 18, e0289358 (2023).","journal-title":"PLoS ONE"},{"key":"1730_CR98","first-page":"161","volume":"2","author":"AM Ardekani","year":"2010","unstructured":"Ardekani, A. M. & Naeini, M. M. The role of microRNAs in human diseases. Avicenna J. Med. Biotechnol. 2, 161 (2010).","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"1730_CR99","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3389\/fimmu.2017.01182","volume":"8","author":"RE Drury","year":"2017","unstructured":"Drury, R. E., O\u2019Connor, D. & Pollard, A. J. The clinical application of microRNAs in infectious disease. Front. Immunol. 8, 1182 (2017).","journal-title":"Front. Immunol."},{"key":"1730_CR100","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1172\/JCI67604","volume":"123","author":"A Dorhoi","year":"2013","unstructured":"Dorhoi, A. et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J. Clin. Invest. 123, 4836\u20134848 (2013).","journal-title":"J. Clin. Invest."},{"key":"1730_CR101","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1089\/gtmb.2015.0090","volume":"19","author":"X Xi","year":"2015","unstructured":"Xi, X. et al. MicroRNA-223 is upregulated in active tuberculosis patients and inhibits apoptosis of macrophages by targeting FOXO3. Genet. Test. Mol. Biomarkers 19, 650\u2013656 (2015).","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"1730_CR102","doi-asserted-by":"publisher","first-page":"1027472","DOI":"10.3389\/fimmu.2022.1027472","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. MicroRNAs as immune regulators and biomarkers in tuberculosis. Front. Immunol. 13, 1027472 (2022).","journal-title":"Front. Immunol."},{"key":"1730_CR103","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1165\/rcmb.2008-0248OC","volume":"40","author":"M Gonzalez-Juarrero","year":"2009","unstructured":"Gonzalez-Juarrero, M. et al. Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease. Am. J. Respir. Cell Mol. Biol. 40, 398\u2013409 (2009).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1730_CR104","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1016\/j.cell.2022.10.025","volume":"185","author":"JAL Flynn","year":"2022","unstructured":"Flynn, J. A. L. & Chan, J. Immune cell interactions in tuberculosis. Cell 185, 4682\u20134702 (2022).","journal-title":"Cell"},{"key":"1730_CR105","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/ijms23031619","volume":"23","author":"SW Pan","year":"2022","unstructured":"Pan, S. W. et al. PD-L1 expression in monocytes correlates with bacterial burden and treatment outcomes in active pulmonary tuberculosis. Int. J. Mol. Sci. 23, 1619 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1730_CR106","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.4049\/jimmunol.2000532","volume":"205","author":"MR D\u2019Agostino","year":"2020","unstructured":"D\u2019Agostino, M. R. et al. Airway macrophages mediate mucosal vaccine-induced trained innate immunity against Mycobacterium tuberculosis in early stages of infection. J. Immunol. 205, 2750\u20132762 (2020).","journal-title":"J. Immunol."},{"key":"1730_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52846-w","volume":"15","author":"D Pisu","year":"2024","unstructured":"Pisu, D., Johnston, L., Mattila, J. T. & Russell, D. G. The frequency of CD38+ alveolar macrophages correlates with early control of M. tuberculosis in the murine lung. Nat. Commun. 15, 8522 (2024).","journal-title":"Nat. Commun."},{"key":"1730_CR108","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/imm.13825","volume":"173","author":"MS Cardoso","year":"2024","unstructured":"Cardoso, M. S. et al. CD5L is upregulated upon infection with Mycobacterium tuberculosis with no effect on disease progression. Immunology 173, 310\u2013320 (2024).","journal-title":"Immunology"},{"key":"1730_CR109","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.4049\/jimmunol.1201819","volume":"191","author":"K Schaale","year":"2013","unstructured":"Schaale, K. et al. Wnt6 is expressed in granulomatous lesions of Mycobacterium tuberculosis-infected mice and is involved in macrophage differentiation and proliferation. J. Immunol. 191, 5182\u20135195 (2013).","journal-title":"J. Immunol."},{"key":"1730_CR110","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1164\/rccm.201304-0803OC","volume":"188","author":"R Gopal","year":"2013","unstructured":"Gopal, R. et al. S100A8\/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. Am. J. Respir. Crit. Care Med. 188, 1137\u20131146 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1730_CR111","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1172\/JCI130546","volume":"130","author":"NR Scott","year":"2020","unstructured":"Scott, N. R. et al. S100A8\/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis. J. Clin. Invest. 130, 3098\u20133112 (2020).","journal-title":"J. Clin. Invest."},{"key":"1730_CR112","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/infdis\/jiy586","volume":"219","author":"EP Amaral","year":"2019","unstructured":"Amaral, E. P. et al. Inhibiting adenosine receptor signaling promotes accumulation of effector CD4+ T cells in the lung parenchyma during severe tuberculosis. J. Infect. Dis. 219, 964\u2013974 (2019).","journal-title":"J. Infect. Dis."},{"key":"1730_CR113","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1084\/jem.20141518","volume":"212","author":"AO Moguche","year":"2015","unstructured":"Moguche, A. O. et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis. J. Exp. Med. 212, 715\u2013728 (2015).","journal-title":"J. Exp. Med."},{"key":"1730_CR114","doi-asserted-by":"publisher","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","volume":"190","author":"T Lindenstr\u00f8m","year":"2013","unstructured":"Lindenstr\u00f8m, T., Knudsen, N. P. H., Agger, E. M. & Andersen, P. Control of chronic Mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells. J. Immunol. 190, 6311\u20136319 (2013).","journal-title":"J. Immunol."},{"key":"1730_CR115","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.tube.2015.11.008","volume":"97","author":"MC Boer","year":"2016","unstructured":"Boer, M. C. et al. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults. Tuberculosis 97, 163\u2013171 (2016).","journal-title":"Tuberculosis"},{"key":"1730_CR116","doi-asserted-by":"publisher","first-page":"1538127","DOI":"10.3389\/fimmu.2025.1538127","volume":"16","author":"H Gunasekaran","year":"2025","unstructured":"Gunasekaran, H., Ranganathan, U. D. & Bethunaickan, R. The importance of inflammatory biomarkers in detecting and managing latent tuberculosis infection. Front. Immunol. 16, 1538127 (2025).","journal-title":"Front. Immunol."},{"key":"1730_CR117","doi-asserted-by":"publisher","first-page":"109696","DOI":"10.1016\/j.celrep.2021.109696","volume":"36","author":"YJ Lu","year":"2021","unstructured":"Lu, Y. J. et al. CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection. Cell Rep. 36, 109696 (2021).","journal-title":"Cell Rep."},{"key":"1730_CR118","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nprot.2014.005","volume":"9","author":"KG Anderson","year":"2014","unstructured":"Anderson, K. G. et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9, 209\u2013222 (2014).","journal-title":"Nat. Protoc."},{"key":"1730_CR119","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.4049\/jimmunol.1400019","volume":"192","author":"S Sakai","year":"2014","unstructured":"Sakai, S. et al. Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells. J. Immunol. 192, 2965\u20132969 (2014).","journal-title":"J. Immunol."},{"key":"1730_CR120","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/mi.2016.70","volume":"10","author":"JS Woodworth","year":"2017","unstructured":"Woodworth, J. S. et al. Subunit vaccine H56\/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung. Mucosal Immunol. 10, 555\u2013564 (2017).","journal-title":"Mucosal Immunol."},{"key":"1730_CR121","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1016\/j.celrep.2017.03.007","volume":"18","author":"MA Sallin","year":"2017","unstructured":"Sallin, M. A. et al. Th1 differentiation drives the accumulation of intravascular, non-protective CD4 T cells during tuberculosis. Cell Rep. 18, 3091\u20133104 (2017).","journal-title":"Cell Rep."},{"key":"1730_CR122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005667","volume":"12","author":"S Sakai","year":"2016","unstructured":"Sakai, S. et al. CD4 T cell-derived IFN-\u03b3 plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease. PLoS Pathog. 12, e1005667 (2016).","journal-title":"PLoS Pathog."},{"key":"1730_CR123","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1128\/IAI.01133-10","volume":"79","author":"LN Lee","year":"2011","unstructured":"Lee, L. N. et al. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis. Infect. Immun. 79, 3328\u20133337 (2011).","journal-title":"Infect. Immun."},{"key":"1730_CR124","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fcimb.2017.00314","volume":"7","author":"S Park","year":"2017","unstructured":"Park, S. et al. Unique chemokine profiles of lung tissues distinguish post-chemotherapeutic persistent and chronic tuberculosis in a mouse model. Front. Cell. Infect. Microbiol. 7, 314 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1730_CR125","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.4049\/jimmunol.1901326","volume":"204","author":"Q Yang","year":"2020","unstructured":"Yang, Q. et al. Cutting edge: characterization of human tissue-resident memory T cells at different infection sites in patients with tuberculosis. J. Immunol. 204, 2331\u20132336 (2020).","journal-title":"J. Immunol."},{"key":"1730_CR126","first-page":"1141","volume":"8","author":"MKK Niazi","year":"2015","unstructured":"Niazi, M. K. K. et al. Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice. Dis. Model. Mech. 8, 1141\u20131153 (2015).","journal-title":"Dis. Model. Mech."},{"key":"1730_CR127","doi-asserted-by":"publisher","first-page":"854507","DOI":"10.1155\/2015\/854507","volume":"2015","author":"IV Lyadova","year":"2015","unstructured":"Lyadova, I. V. & Panteleev, A. V. Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers. Mediators Inflamm. 2015, 854507 (2015).","journal-title":"Mediators Inflamm."},{"key":"1730_CR128","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tube.2014.10.012","volume":"95","author":"MC Garcia-Pelayo","year":"2015","unstructured":"Garcia-Pelayo, M. C., Bachy, V. S., Kaveh, D. A. & Hogarth, P. J. BALB\/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL\/6 mice but have equivalent protection. Tuberculosis 95, 48\u201353 (2015).","journal-title":"Tuberculosis"},{"key":"1730_CR129","doi-asserted-by":"publisher","first-page":"102540","DOI":"10.1016\/j.tube.2024.102540","volume":"148","author":"SC Derrick","year":"2024","unstructured":"Derrick, S. C., Yang, A. & Cowley, S. Enhanced efficacy of BCG vaccine formulated in adjuvant is dependent on IL-17A expression. Tuberculosis 148, 102540 (2024).","journal-title":"Tuberculosis"},{"key":"1730_CR130","doi-asserted-by":"publisher","first-page":"e0239668","DOI":"10.1371\/journal.pone.0239668","volume":"15","author":"T Kondratieva","year":"2020","unstructured":"Kondratieva, T. et al. Prolonged infection triggered by dormant Mycobacterium tuberculosis: immune and inflammatory responses in lungs of genetically susceptible and resistant mice. PLoS ONE 15, e0239668 (2020).","journal-title":"PLoS ONE"},{"key":"1730_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/srep36720","volume":"6","author":"MG Booty","year":"2016","unstructured":"Booty, M. G. et al. IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infection. Sci. Rep. 6, 36720 (2016).","journal-title":"Sci. Rep."},{"key":"1730_CR132","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3389\/fimmu.2018.00471","volume":"9","author":"LN Velasquez","year":"2018","unstructured":"Velasquez, L. N. et al. Targeting Mycobacterium tuberculosis antigens to dendritic cells via the DC-specific-ICAM3-grabbing-nonintegrin receptor induces strong T-helper 1 immune responses. Front. Immunol. 9, 471 (2018).","journal-title":"Front. Immunol."},{"key":"1730_CR133","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/imm.12411","volume":"144","author":"CA S\u00e9rgio","year":"2015","unstructured":"S\u00e9rgio, C. A., Bertolini, T. B., Gembre, A. F., Prado, R. Q. & Bonato, V. L. D. CD11c(+) CD103(+) cells of Mycobacterium tuberculosis-infected C57BL\/6 but not of BALB\/c mice induce a high frequency of interferon-\u03b3- or interleukin-17-producing CD4(+) cells. Immunology 144, 574\u2013586 (2015).","journal-title":"Immunology"},{"key":"1730_CR134","doi-asserted-by":"publisher","first-page":"69287","DOI":"10.1371\/journal.pone.0069287","volume":"8","author":"C Leepiyasakulchai","year":"2013","unstructured":"Leepiyasakulchai, C. et al. Infection rate and tissue localization of murine IL-12p40-producing monocyte-derived CD103+ lung dendritic cells during pulmonary tuberculosis. PLoS ONE 8, 69287 (2013).","journal-title":"PLoS ONE"},{"key":"1730_CR135","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4049\/jimmunol.178.2.976","volume":"178","author":"MA Kapina","year":"2007","unstructured":"Kapina, M. A. et al. CD27low CD4 T lymphocytes that accumulate in the mouse lungs during mycobacterial infection differentiate from CD27high precursors in situ, produce IFN-gamma, and protect the host against tuberculosis infection. J. Immunol. 178, 976\u2013985 (2007).","journal-title":"J. Immunol."},{"key":"1730_CR136","first-page":"412860","volume":"10","author":"I Latorre","year":"2019","unstructured":"Latorre, I. et al. Study of CD27 and CCR4 markers on specific CD4+ T-cells as immune tools for active and latent tuberculosis management. Front. Immunol. 10, 412860 (2019).","journal-title":"Front. Immunol."},{"key":"1730_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.885312","volume":"13","author":"S D\u00edaz-Fern\u00e1ndez","year":"2022","unstructured":"D\u00edaz-Fern\u00e1ndez, S. et al. Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment. Front. Microbiol. 13, 885312 (2022).","journal-title":"Front. Microbiol."},{"key":"1730_CR138","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01516-16","volume":"7","author":"CM Smith","year":"2016","unstructured":"Smith, C. M. et al. Tuberculosis susceptibility and vaccine protection are independently controlled by host genotype. mBio 7, e01516-16 (2016).","journal-title":"mBio"},{"key":"1730_CR139","doi-asserted-by":"crossref","unstructured":"Smith, C. M. & Sassetti, C. M. Modeling diversity: do homogeneous laboratory strains limit discovery? Trends Microbiol. 26, 892\u2013895 (2018).","DOI":"10.1016\/j.tim.2018.08.002"},{"key":"1730_CR140","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00097-20","volume":"5","author":"SL Kurtz","year":"2020","unstructured":"Kurtz, S. L. et al. The Diversity Outbred mouse population is an improved animal model of vaccination against tuberculosis that reflects heterogeneity of protection. mSphere 5, e00097-20 (2020).","journal-title":"mSphere"},{"key":"1730_CR141","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.74419","volume":"11","author":"CM Smith","year":"2022","unstructured":"Smith, C. M. et al. Host\u2013pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice. eLife 11, e74419 (2022).","journal-title":"eLife"},{"key":"1730_CR142","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02791-19","volume":"10","author":"CM Smith","year":"2019","unstructured":"Smith, C. M. et al. Functionally overlapping variants control tuberculosis susceptibility in Collaborative Cross mice. mBio 10, e02791-19 (2019).","journal-title":"mBio"},{"key":"1730_CR143","doi-asserted-by":"publisher","DOI":"10.1172\/JCI167762","volume":"133","author":"R Lai","year":"2023","unstructured":"Lai, R. et al. Host genetic background is a barrier to broadly effective vaccine\u2013mediated protection against tuberculosis. J. Clin. Invest. 133, e167762 (2023).","journal-title":"J. Clin. Invest."},{"key":"1730_CR144","doi-asserted-by":"publisher","first-page":"613149","DOI":"10.3389\/fcimb.2021.613149","volume":"11","author":"H-J Yang","year":"2021","unstructured":"Yang, H.-J., Wang, D., Wen, X., Weiner, D. M. & Via, L. E. One size fits all? Not in in vivo modeling of tuberculosis chemotherapeutics. Front. Cell. Infect. Microbiol. 11, 613149 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1730_CR145","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00168-23","volume":"91","author":"SL Kurtz","year":"2023","unstructured":"Kurtz, S. L. et al. Intravenous BCG vaccination of Diversity Outbred mice results in moderately enhanced protection against challenge with Mycobacterium tuberculosis compared to intradermal vaccination. Infect. Immun. 91, e0016823 (2023).","journal-title":"Infect. Immun."},{"key":"1730_CR146","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158630","volume":"133","author":"S Thirunavukkarasu","year":"2023","unstructured":"Thirunavukkarasu, S. et al. Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production. J. Clin. Invest. 133, e158630 (2023).","journal-title":"J. Clin. Invest."},{"key":"1730_CR147","doi-asserted-by":"publisher","first-page":"eaay0233","DOI":"10.1126\/scitranslmed.aay0233","volume":"12","author":"M Ahmed","year":"2020","unstructured":"Ahmed, M. et al. Immune correlates of tuberculosis disease and risk translate across species. Sci. Transl. Med. 12, eaay0233 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1730_CR148","doi-asserted-by":"publisher","first-page":"ftz037","DOI":"10.1093\/femspd\/ftz037","volume":"77","author":"AN Bucsan","year":"2019","unstructured":"Bucsan, A. N., Mehra, S., Khader, S. A. & Kaushal, D. The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease. Pathog. Dis. 77, ftz037 (2019).","journal-title":"Pathog. Dis."},{"key":"1730_CR149","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1017\/S0022172400039164","volume":"59","author":"DF Gray","year":"1961","unstructured":"Gray, D. F. The relative natural resistance of rats and mice to experimental pulmonary tuberculosis. Epidemiol. Infect. 59, 471\u2013478 (1961).","journal-title":"Epidemiol. Infect."},{"key":"1730_CR150","doi-asserted-by":"publisher","unstructured":"Li, H. & Li, H. in Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges (ed. Christodoulides, M.) 139\u2013170 (Springer, 2023); https:\/\/doi.org\/10.1007\/978-3-031-24355-4_7","DOI":"10.1007\/978-3-031-24355-4_7"},{"key":"1730_CR151","doi-asserted-by":"publisher","first-page":"1223260","DOI":"10.3389\/fimmu.2023.1223260","volume":"14","author":"B Corleis","year":"2023","unstructured":"Corleis, B., Bastian, M., Hoffmann, D., Beer, M. & Dorhoi, A. Animal models for COVID-19 and tuberculosis. Front. Immunol. 14, 1223260 (2023).","journal-title":"Front. Immunol."},{"key":"1730_CR152","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/jat.4324","volume":"42","author":"K Muta","year":"2022","unstructured":"Muta, K. et al. Phosphatidylcholine (18:0\/20:4), a potential biomarker to predict ethionamide-induced hepatic steatosis in rats. J. Appl. Toxicol. 42, 1533\u20131547 (2022).","journal-title":"J. Appl. Toxicol."},{"key":"1730_CR153","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1039\/C6TX00245E","volume":"6","author":"H Zhao","year":"2017","unstructured":"Zhao, H. et al. Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a 1H NMR based metabolomics approach. Toxicol. Res. 6, 17\u201329 (2017).","journal-title":"Toxicol. Res."},{"key":"1730_CR154","doi-asserted-by":"publisher","first-page":"248","DOI":"10.5455\/medarh.2022.76.248-251","volume":"76","author":"B Singh","year":"2022","unstructured":"Singh, B., Wasita, B. & Reviono, R. Kinetics of granuloma, IFN-\u03b3 and IP-10 in a Wistar rat model infected with Mycobacterium tuberculosis. Med. Arch. 76, 248 (2022).","journal-title":"Med. Arch."},{"key":"1730_CR155","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.0959-9673.2004.00379.x","volume":"85","author":"I Sugawara","year":"2004","unstructured":"Sugawara, I., Yamada, H. & Mizuno, S. Pathological and immunological profiles of rat tuberculosis. Int. J. Exp. Pathol. 85, 125\u2013134 (2004).","journal-title":"Int. J. Exp. Pathol."},{"key":"1730_CR156","first-page":"157","volume":"215","author":"DN Mcmurray","year":"1996","unstructured":"Mcmurray, D. N., Collins, F. M., Dannenberg, A. M. & Smith, D. W. Pathogenesis of experimental tuberculosis in animal models. Curr. Top. Microbiol. Immunol. 215, 157\u2013179 (1996).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"1730_CR157","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1002\/cpz1.312","volume":"1","author":"E Creissen","year":"2021","unstructured":"Creissen, E., Izzo, L., Dawson, C. & Izzo, A. A. Guinea pig model of Mycobacterium tuberculosis Infection. Curr. Protoc. 1, e312 (2021).","journal-title":"Curr. Protoc."},{"key":"1730_CR158","doi-asserted-by":"publisher","first-page":"45","DOI":"10.30802\/AALAS-CM-19-000047","volume":"70","author":"WR Williams","year":"2020","unstructured":"Williams, W. R. et al. Evaluation of peripheral blood markers as early endpoint criteria in guinea pigs (Cavia porcellus) when testing tuberculosis vaccine candidates. Comp. Med. 70, 45\u201355 (2020).","journal-title":"Comp. Med."},{"key":"1730_CR159","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1128\/jb.91.2.718-724.1966","volume":"91","author":"DW Smith","year":"1966","unstructured":"Smith, D. W., Wiegeshaus, E., Navalkar, R. & Grover, A. A. Host\u2013parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals. J. Bacteriol. 91, 718\u2013724 (1966).","journal-title":"J. Bacteriol."},{"key":"1730_CR160","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1128\/IAI.71.2.864-871.2003","volume":"71","author":"OC Turner","year":"2003","unstructured":"Turner, O. C., Basaraba, R. J. & Orme, I. M. Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis. Infect. Immun. 71, 864\u2013871 (2003).","journal-title":"Infect. Immun."},{"key":"1730_CR161","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1054\/tuld.1998.0207","volume":"79","author":"DN McMurray","year":"1999","unstructured":"McMurray, D. N., Dai, G. & Phalen, S. Mechanisms of vaccine-induced resistance in a guinea pig model of pulmonary tuberculosis. Tuber. Lung Dis. 79, 261\u2013266 (1999).","journal-title":"Tuber. Lung Dis."},{"key":"1730_CR162","first-page":"937","volume":"102","author":"DW Smith","year":"1970","unstructured":"Smith, D. W., McMurray, D. N., Wiegeshaus, E. H., Grover, A. A. & Harding, G. E. Host\u2013parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs. Am. Rev. Respir. Dis. 102, 937\u2013949 (1970).","journal-title":"Am. Rev. Respir. Dis."},{"key":"1730_CR163","doi-asserted-by":"publisher","first-page":"619480","DOI":"10.1155\/2015\/619480","volume":"2015","author":"VR Dirisala","year":"2015","unstructured":"Dirisala, V. R., Jeevan, A., Ly, L. H. & McMurray, D. N. Molecular and biochemical characterization of recombinant guinea pig tumor necrosis factor-alpha. Mediators Inflamm. 2015, 619480 (2015).","journal-title":"Mediators Inflamm."},{"key":"1730_CR164","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s12033-013-9679-z","volume":"55","author":"VR Dirisala","year":"2013","unstructured":"Dirisala, V. R., Jeevan, A., Ramasamy, S. K. & McMurray, D. N. Molecular cloning, expression, and in silico structural analysis of guinea pig IL-17. Mol. Biotechnol. 55, 277\u2013287 (2013).","journal-title":"Mol. Biotechnol."},{"key":"1730_CR165","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2012.01.076","volume":"498","author":"VR Dirisala","year":"2012","unstructured":"Dirisala, V. R., Jeevan, A., Bix, G., Yoshimura, T. & McMurray, D. N. Molecular cloning and expression of the IL-10 gene from guinea pigs. Gene 498, 120\u2013127 (2012).","journal-title":"Gene"},{"key":"1730_CR166","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.molimm.2006.03.023","volume":"44","author":"M Takahashi","year":"2007","unstructured":"Takahashi, M., Jeevan, A., Sawant, K., McMurray, D. N. & Yoshimura, T. Cloning and characterization of guinea pig CXCR1. Mol. Immunol. 44, 878\u2013888 (2007).","journal-title":"Mol. Immunol."},{"key":"1730_CR167","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1189\/jlb.0704414","volume":"76","author":"TA Skwor","year":"2004","unstructured":"Skwor, T. A., Cho, H., Cassidy, C., Yoshimura, T. & McMurray, D. N. Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages. J. Leukoc. Biol. 76, 1229\u20131239 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"1730_CR168","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1165\/rcmb.2007-0326OC","volume":"38","author":"LH Ly","year":"2008","unstructured":"Ly, L. H., Russell, M. I. & McMurray, D. N. Cytokine profiles in primary and secondary pulmonary granulomas of guinea pigs with tuberculosis. Am. J. Respir. Cell Mol. Biol. 38, 455\u2013462 (2008).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1730_CR169","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1462-5822.2006.00854.x","volume":"9","author":"LH Ly","year":"2007","unstructured":"Ly, L. H., Russell, M. I. & Mcmurray, D. N. Microdissection of the cytokine milieu of pulmonary granulomas from tuberculous guinea pigs. Cell. Microbiol. 9, 1127\u20131136 (2007).","journal-title":"Cell. Microbiol."},{"key":"1730_CR170","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.tube.2005.12.001","volume":"87","author":"H Cho","year":"2007","unstructured":"Cho, H. & McMurray, D. N. Recombinant guinea pig TNF-alpha enhances antigen-specific type 1 T lymphocyte activation in guinea pig splenocytes. Tuberculosis 87, 87\u201393 (2007).","journal-title":"Tuberculosis"},{"key":"1730_CR171","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1128\/IAI.74.1.213-224.2006","volume":"74","author":"A Jeevan","year":"2006","unstructured":"Jeevan, A. et al. Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation. Infect. Immun. 74, 213\u2013224 (2006).","journal-title":"Infect. Immun."},{"key":"1730_CR172","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tube.2005.01.001","volume":"85","author":"TM Lasco","year":"2005","unstructured":"Lasco, T. M., Cassone, L., Kamohara, H., Yoshimura, T. & McMurray, D. N. Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig. Tuberculosis 85, 245\u2013258 (2005).","journal-title":"Tuberculosis"},{"key":"1730_CR173","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.1128\/IAI.00704-09","volume":"77","author":"A Grover","year":"2009","unstructured":"Grover, A. et al. Kinetics of the immune response profile in guinea pigs after vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis. Infect. Immun. 77, 4837\u20134846 (2009).","journal-title":"Infect. Immun."},{"key":"1730_CR174","doi-asserted-by":"publisher","first-page":"e00142","DOI":"10.1128\/CVI.00142-17","volume":"24","author":"MJ Brennan","year":"2017","unstructured":"Brennan, M. J. et al. The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010\u20132014. Clin. Vaccine Immunol. 24, e00142\u201317 (2017).","journal-title":"Clin. Vaccine Immunol."},{"key":"1730_CR175","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1128\/IAI.72.3.1700-1705.2004","volume":"72","author":"SE Dorman","year":"2004","unstructured":"Dorman, S. E. et al. Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand white rabbits. Infect. Immun. 72, 1700\u20131705 (2004).","journal-title":"Infect. Immun."},{"key":"1730_CR176","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.1128\/IAI.71.10.6004-6011.2003","volume":"71","author":"YC Manabe","year":"2003","unstructured":"Manabe, Y. C. et al. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infect. Immun. 71, 6004\u20136011 (2003).","journal-title":"Infect. Immun."},{"key":"1730_CR177","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.ajpath.2012.07.019","volume":"181","author":"S Subbian","year":"2012","unstructured":"Subbian, S. et al. Spontaneous latency in a rabbit model of pulmonary tuberculosis. Am. J. Pathol. 181, 1711\u20131724 (2012).","journal-title":"Am. J. Pathol."},{"key":"1730_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tube.2016.07.008","volume":"101","author":"A Dehnad","year":"2016","unstructured":"Dehnad, A., Ravindran, R., Subbian, S. & Khan, I. H. Development of immune-biomarkers of pulmonary tuberculosis in a rabbit model. Tuberculosis 101, 1\u20137 (2016).","journal-title":"Tuberculosis"},{"key":"1730_CR179","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.micinf.2017.10.008","volume":"20","author":"JP Ayyappan","year":"2018","unstructured":"Ayyappan, J. P., Vinnard, C., Subbian, S. & Nagajyothi, J. F. Effect of Mycobacterium tuberculosis infection on adipocyte physiology. Microbes Infect. 20, 81\u201388 (2018).","journal-title":"Microbes Infect."},{"key":"1730_CR180","doi-asserted-by":"publisher","first-page":"7786","DOI":"10.1126\/scitranslmed.aai7786","volume":"10","author":"D Rifat","year":"2018","unstructured":"Rifat, D. et al. Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data. Sci. Transl. Med. 10, 7786 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1730_CR181","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1128\/AAC.03085-15","volume":"60","author":"JP Lanoix","year":"2016","unstructured":"Lanoix, J. P. et al. High systemic exposure of pyrazinoic acid has limited antituberculosis activity in murine and rabbit models of tuberculosis. Antimicrob. Agents Chemother. 60, 4197\u20134205 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1730_CR182","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1021\/ac1029049","volume":"83","author":"B Prideaux","year":"2011","unstructured":"Prideaux, B. et al. High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. Anal. Chem. 83, 2112\u20132118 (2011).","journal-title":"Anal. Chem."},{"key":"1730_CR183","doi-asserted-by":"publisher","first-page":"e41115","DOI":"10.7554\/eLife.41115","volume":"7","author":"L Blanc","year":"2018","unstructured":"Blanc, L. et al. High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell types. eLife 7, e41115 (2018).","journal-title":"eLife"},{"key":"1730_CR184","doi-asserted-by":"publisher","first-page":"e00924","DOI":"10.1128\/AAC.00924-17","volume":"61","author":"M Zimmerman","year":"2017","unstructured":"Zimmerman, M. et al. Ethambutol partitioning in tuberculous pulmonary lesions explains its clinical efficacy. Antimicrob. Agents Chemother. 61, e00924\u201317 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1730_CR185","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2321336121","volume":"121","author":"M Datta","year":"2024","unstructured":"Datta, M. et al. Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits. Proc. Natl Acad. Sci. USA 121, e2321336121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1730_CR186","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ebiom.2016.01.015","volume":"4","author":"S Subbian","year":"2016","unstructured":"Subbian, S. et al. Adjunctive phosphodiesterase-4 inhibitor therapy improves antibiotic response to pulmonary tuberculosis in a rabbit model. eBioMedicine 4, 104\u2013114 (2016).","journal-title":"eBioMedicine"},{"key":"1730_CR187","doi-asserted-by":"publisher","first-page":"e0002421","DOI":"10.1128\/AAC.00024-21","volume":"65","author":"O Egbelowo","year":"2021","unstructured":"Egbelowo, O. et al. Pharmacokinetics and target attainment of SQ109 in plasma and human-like tuberculosis lesions in rabbits. Antimicrob. Agents Chemother. 65, e0002421 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1730_CR188","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4161\/viru.1.3.11748","volume":"1","author":"G Zhang","year":"2010","unstructured":"Zhang, G. et al. Evaluation of mycobacterial virulence using rabbit skin liquefaction model. Virulence 1, 156\u2013163 (2010).","journal-title":"Virulence"},{"key":"1730_CR189","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.tube.2012.03.005","volume":"92","author":"H Sun","year":"2012","unstructured":"Sun, H. et al. Effects of immunomodulators on liquefaction and ulceration in the rabbit skin model of tuberculosis. Tuberculosis 92, 345\u2013350 (2012).","journal-title":"Tuberculosis"},{"key":"1730_CR190","first-page":"235769","volume":"8","author":"H Chen","year":"2017","unstructured":"Chen, H. et al. A new rabbit-skin model to evaluate protective efficacy of tuberculosis vaccines. Front. Microbiol. 8, 235769 (2017).","journal-title":"Front. Microbiol."},{"key":"1730_CR191","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/infdis\/jiu449","volume":"211","author":"B Luna","year":"2015","unstructured":"Luna, B. et al. In vivo prediction of tuberculosis-associated cavity formation in rabbits. J. Infect. Dis. 211, 481\u2013485 (2015).","journal-title":"J. Infect. Dis."},{"key":"1730_CR192","doi-asserted-by":"publisher","first-page":"102255362412667","DOI":"10.1177\/10225536241266703","volume":"32","author":"J Jia","year":"2024","unstructured":"Jia, J. et al. The rabbit model for spinal tuberculosis: an overview. J. Orthop. Surg. 32, 10225536241266704 (2024).","journal-title":"J. Orthop. Surg."},{"key":"1730_CR193","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4196\/kjpp.2018.22.4.369","volume":"22","author":"W Wang","year":"2018","unstructured":"Wang, W., Yang, B., Cui, Y. & Zhan, Y. Isoliquiritigenin attenuates spinal tuberculosis through inhibiting immune response in a New Zealand white rabbit model. Korean J. Physiol. Pharmacol. 22, 369 (2018).","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"1730_CR194","doi-asserted-by":"publisher","first-page":"103048","DOI":"10.1016\/j.amsu.2021.103048","volume":"72","author":"T Risantoso","year":"2021","unstructured":"Risantoso, T., Hidayat, M., Suyuti, H. & Aulann\u2019iam The experimental study of TNF-\u03b1 & CRP expression in the spinal tuberculosis after instrumentation. Ann. Med. Surg. 72, 103048 (2021).","journal-title":"Ann. Med. Surg."},{"key":"1730_CR195","doi-asserted-by":"publisher","first-page":"1264833","DOI":"10.3389\/fvets.2023.1264833","volume":"10","author":"L Hunter","year":"2023","unstructured":"Hunter, L., Ruedas-Torres, I., Agull\u00f3-Ros, I., Rayner, E. & Salguero, F. J. Comparative pathology of experimental pulmonary tuberculosis in animal models. Front. Vet. Sci. 10, 1264833 (2023).","journal-title":"Front. Vet. Sci."},{"key":"1730_CR196","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1128\/CVI.05323-11","volume":"18","author":"B P\u00e9rez De Val","year":"2011","unstructured":"P\u00e9rez De Val, B. et al. Experimental model of tuberculosis in the domestic goat after endobronchial infection with Mycobacterium caprae. Clin. Vaccine Immunol. 18, 1872\u20131881 (2011).","journal-title":"Clin. Vaccine Immunol."},{"key":"1730_CR197","doi-asserted-by":"publisher","first-page":"108758","DOI":"10.1016\/j.vetmic.2020.108758","volume":"247","author":"J Sabio y Garc\u00eda","year":"2020","unstructured":"Sabio y Garc\u00eda, J. et al. Does Mycobacterium bovis persist in cattle in a non-replicative latent state as Mycobacterium tuberculosis in human beings? Vet. Microbiol. 247, 108758 (2020).","journal-title":"Vet. Microbiol."},{"key":"1730_CR198","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1472-9792(02)00062-8","volume":"83","author":"RG Hewinson","year":"2003","unstructured":"Hewinson, R. G., Vordermeier, H. M. & Buddle, B. M. Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics. Tuberculosis 83, 119\u2013130 (2003).","journal-title":"Tuberculosis"},{"key":"1730_CR199","doi-asserted-by":"publisher","first-page":"e0155440","DOI":"10.1371\/journal.pone.0155440","volume":"11","author":"SDC Parsons","year":"2016","unstructured":"Parsons, S. D. C. et al. Antigen-specific IP-10 release is a sensitive biomarker of Mycobacterium bovis infection in cattle. PLoS ONE 11, e0155440 (2016).","journal-title":"PLoS ONE"},{"key":"1730_CR200","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.rvsc.2018.10.016","volume":"122","author":"LI Klepp","year":"2019","unstructured":"Klepp, L. I. et al. Identification of bovine tuberculosis biomarkers to detect tuberculin skin test and IFN\u03b3 release assay false negative cattle. Res. Vet. Sci. 122, 7\u201314 (2019).","journal-title":"Res. Vet. Sci."},{"key":"1730_CR201","doi-asserted-by":"publisher","first-page":"109988","DOI":"10.1016\/j.vetimm.2019.109988","volume":"220","author":"MV Palmer","year":"2020","unstructured":"Palmer, M. V. et al. Biomarkers of cell-mediated immunity to bovine tuberculosis. Vet. Immunol. Immunopathol. 220, 109988 (2020).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"1730_CR202","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1128\/IAI.70.6.3026-3032.2002","volume":"70","author":"HM Vordermeier","year":"2002","unstructured":"Vordermeier, H. M. et al. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 70, 3026\u20133032 (2002).","journal-title":"Infect. Immun."},{"key":"1730_CR203","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tube.2010.11.007","volume":"91","author":"FC Blanco","year":"2011","unstructured":"Blanco, F. C. et al. Increased IL-17 expression is associated with pathology in a bovine model of tuberculosis. Tuberculosis 91, 57\u201363 (2011).","journal-title":"Tuberculosis"},{"key":"1730_CR204","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1128\/IAI.00287-09","volume":"77","author":"HM Vordermeier","year":"2009","unstructured":"Vordermeier, H. M. et al. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun. 77, 3364\u20133373 (2009).","journal-title":"Infect. Immun."},{"key":"1730_CR205","doi-asserted-by":"publisher","first-page":"e81317","DOI":"10.1371\/journal.pone.0081317","volume":"8","author":"B P\u00e9rez De Val","year":"2013","unstructured":"P\u00e9rez De Val, B. et al. A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression. PLoS ONE 8, e81317 (2013).","journal-title":"PLoS ONE"},{"key":"1730_CR206","doi-asserted-by":"publisher","first-page":"7276","DOI":"10.1016\/j.vaccine.2015.10.113","volume":"33","author":"L Blunt","year":"2015","unstructured":"Blunt, L. et al. Phenotypic characterization of bovine memory cells responding to mycobacteria in IFN\u03b3 enzyme linked immunospot assays. Vaccine 33, 7276\u20137282 (2015).","journal-title":"Vaccine"},{"key":"1730_CR207","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26683-0","volume":"12","author":"C Melgarejo","year":"2022","unstructured":"Melgarejo, C. et al. A proof-of-concept study to investigate the efficacy of heat-inactivated autovaccines in Mycobacterium caprae experimentally challenged goats. Sci. Rep. 12, 22132 (2022).","journal-title":"Sci. Rep."},{"key":"1730_CR208","doi-asserted-by":"publisher","first-page":"e0212751","DOI":"10.1371\/journal.pone.0212751","volume":"14","author":"M Guerra-Maupome","year":"2019","unstructured":"Guerra-Maupome, M., Vang, D. X. & McGill, J. L. Aerosol vaccination with Bacille Calmette\u2013Guerin induces a trained innate immune phenotype in calves. PLoS ONE 14, e0212751 (2019).","journal-title":"PLoS ONE"},{"key":"1730_CR209","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1128\/IAI.72.5.2462-2467.2004","volume":"72","author":"K Lyashchenko","year":"2004","unstructured":"Lyashchenko, K. et al. Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis. Infect. Immun. 72, 2462\u20132467 (2004).","journal-title":"Infect. Immun."},{"key":"1730_CR210","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1111\/tbed.14365","volume":"69","author":"J Ruiz-Cabello","year":"2022","unstructured":"Ruiz-Cabello, J. et al. Benchtop nuclear magnetic resonance-based metabolomic approach for the diagnosis of bovine tuberculosis. Transbound. Emerg. Dis. 69, e859\u2013e870 (2022).","journal-title":"Transbound. Emerg. Dis."},{"key":"1730_CR211","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/imr.12258","volume":"264","author":"JL Flynn","year":"2015","unstructured":"Flynn, J. L., Gideon, H. P., Mattila, J. T. & Lin, P. L. Immunology studies in non-human primate models of tuberculosis. Immunol. Rev. 264, 60\u201373 (2015).","journal-title":"Immunol. Rev."},{"key":"1730_CR212","doi-asserted-by":"publisher","first-page":"a018564","DOI":"10.1101\/cshperspect.a018564","volume":"4","author":"CA Scanga","year":"2014","unstructured":"Scanga, C. A. & Flynn, J. L. Modeling tuberculosis in nonhuman primates. Cold Spring Harb. Perspect. Med. 4, a018564 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1730_CR213","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","volume":"25","author":"K Dijkman","year":"2019","unstructured":"Dijkman, K. et al. Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques. Nat. Med. 25, 255\u2013262 (2019).","journal-title":"Nat. Med."},{"key":"1730_CR214","doi-asserted-by":"publisher","first-page":"488237","DOI":"10.3389\/fimmu.2019.02479","volume":"10","author":"K Dijkman","year":"2019","unstructured":"Dijkman, K. et al. Disparate tuberculosis disease development in macaque species is associated with innate immunity. Front. Immunol. 10, 488237 (2019).","journal-title":"Front. Immunol."},{"key":"1730_CR215","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2174\/156652407780598520","volume":"7","author":"H Fletcher","year":"2007","unstructured":"Fletcher, H. Correlates of immune protection from tuberculosis. Curr. Mol. Med. 7, 319\u2013325 (2007).","journal-title":"Curr. Mol. Med."},{"key":"1730_CR216","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","volume":"577","author":"PA Darrah","year":"2020","unstructured":"Darrah, P. A. et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature 577, 95\u2013102 (2020).","journal-title":"Nature"},{"key":"1730_CR217","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/infdis\/jix625","volume":"217","author":"MJ Kuroda","year":"2018","unstructured":"Kuroda, M. J. et al. High turnover of tissue macrophages contributes to tuberculosis reactivation in simian immunodeficiency virus-infected rhesus macaques. J. Infect. Dis. 217, 1865\u20131874 (2018).","journal-title":"J. Infect. Dis."},{"key":"1730_CR218","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.immuni.2022.04.004","volume":"55","author":"HP Gideon","year":"2022","unstructured":"Gideon, H. P. et al. Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control. Immunity 55, 827\u2013846 (2022).","journal-title":"Immunity"},{"key":"1730_CR219","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41385-019-0195-8","volume":"12","author":"HP Gideon","year":"2019","unstructured":"Gideon, H. P., Phuah, J., Junecko, B. A. & Mattila, J. T. Neutrophils express pro- and anti-inflammatory cytokines in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques. Mucosal Immunol. 12, 1370\u20131381 (2019).","journal-title":"Mucosal Immunol."},{"key":"1730_CR220","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1128\/IAI.00632-13","volume":"81","author":"LE Via","year":"2013","unstructured":"Via, L. E. et al. Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus). Infect. Immun. 81, 2909\u20132919 (2013).","journal-title":"Infect. Immun."},{"key":"1730_CR221","first-page":"412","volume":"66","author":"AM Cadena","year":"2016","unstructured":"Cadena, A. M. et al. Very low doses of Mycobacterium tuberculosis yield diverse host outcomes in common marmosets (Callithrix jacchus). Comp. Med. 66, 412\u2013419 (2016).","journal-title":"Comp. Med."},{"key":"1730_CR222","doi-asserted-by":"publisher","first-page":"e00505","DOI":"10.1128\/IAI.00505-17","volume":"86","author":"P Maiello","year":"2018","unstructured":"Maiello, P. et al. Rhesus macaques are more susceptible to progressive tuberculosis than cynomolgus macaques: a quantitative comparison. Infect. Immun. 86, e00505\u2013e00517 (2018).","journal-title":"Infect. Immun."},{"key":"1730_CR223","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1183\/09031936.00089510","volume":"37","author":"SW Lee","year":"2011","unstructured":"Lee, S. W. et al. Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis. Eur. Respir. J. 37, 1447\u20131452 (2011).","journal-title":"Eur. Respir. J."},{"key":"1730_CR224","doi-asserted-by":"publisher","first-page":"706723","DOI":"10.3389\/fimmu.2021.706723","volume":"12","author":"R Sharan","year":"2021","unstructured":"Sharan, R., Singh, D. K., Rengarajan, J. & Kaushal, D. Characterizing early T cell responses in nonhuman primate model of tuberculosis. Front. Immunol. 12, 706723 (2021).","journal-title":"Front. Immunol."},{"key":"1730_CR225","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/mi.2017.60","volume":"11","author":"KD Kauffman","year":"2017","unstructured":"Kauffman, K. D. et al. Defective positioning in granulomas but not lung-homing limits CD4 T-cell interactions with Mycobacterium tuberculosis-infected macrophages in rhesus macaques. Mucosal Immunol. 11, 462\u2013473 (2017).","journal-title":"Mucosal Immunol."},{"key":"1730_CR226","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161564","volume":"132","author":"R Sharan","year":"2022","unstructured":"Sharan, R. et al. Isoniazid and rifapentine treatment effectively reduces persistent M. tuberculosis infection in macaque lungs. J. Clin. Invest. 132, e161564 (2022).","journal-title":"J. Clin. Invest."},{"key":"1730_CR227","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9533","volume":"6","author":"D Kaushal","year":"2015","unstructured":"Kaushal, D. et al. Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis. Nat. Commun. 6, 8533 (2015).","journal-title":"Nat. Commun."},{"key":"1730_CR228","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1128\/CVI.00079-10","volume":"17","author":"SA Sharpe","year":"2010","unstructured":"Sharpe, S. A. et al. Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing. Clin. Vaccine Immunol. 17, 1170\u20131182 (2010).","journal-title":"Clin. Vaccine Immunol."},{"key":"1730_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63041-4","volume":"10","author":"K Dijkman","year":"2020","unstructured":"Dijkman, K. et al. Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosis. Sci. Rep. 10, 6290 (2020).","journal-title":"Sci. Rep."},{"key":"1730_CR230","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nm0496-430","volume":"2","author":"GP Walsh","year":"1996","unstructured":"Walsh, G. P. et al. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat. Med. 2, 430\u2013436 (1996).","journal-title":"Nat. Med."},{"key":"1730_CR231","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s11481-010-9245-4","volume":"6","author":"J Zhang","year":"2011","unstructured":"Zhang, J. et al. M. tuberculosis H37Rv infection of Chinese rhesus macaques. J. Neuroimmune Pharmacol. 6, 362\u2013370 (2011).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"1730_CR232","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153090","volume":"132","author":"R Sharan","year":"2022","unstructured":"Sharan, R. et al. Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis\/SIV coinfection model. J. Clin. Invest. 132, e153090 (2022).","journal-title":"J. Clin. Invest."},{"key":"1730_CR233","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.1172\/JCI125810","volume":"129","author":"AN Buc\u015fan","year":"2019","unstructured":"Buc\u015fan, A. N. et al. Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection. J. Clin. Invest. 129, 5254\u20135260 (2019).","journal-title":"J. Clin. Invest."},{"key":"1730_CR234","first-page":"e56375","volume":"2017","author":"AG White","year":"2017","unstructured":"White, A. G. et al. Analysis of 18FDG PET\/CT imaging as a tool for studying Mycobacterium tuberculosis infection and treatment in non-human primates. J. Vis. Exp. 2017, e56375 (2017).","journal-title":"J. Vis. Exp."},{"key":"1730_CR235","doi-asserted-by":"publisher","first-page":"265ra167","DOI":"10.1126\/scitranslmed.3009500","volume":"6","author":"MT Coleman","year":"2014","unstructured":"Coleman, M. T. et al. PET\/CT monitoring demonstrates a therapeutic response to oxazolidinones in Mycobacterium tuberculosis-infected macaques and humans. Sci. Transl. Med. 6, 265ra167 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1730_CR236","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004603","volume":"11","author":"HP Gideon","year":"2015","unstructured":"Gideon, H. P. et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. PLoS Pathog. 11, e1004603 (2015).","journal-title":"PLoS Pathog."},{"key":"1730_CR237","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/art.27271","volume":"62","author":"PL Lin","year":"2010","unstructured":"Lin, P. L. et al. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum. 62, 340\u2013350 (2010).","journal-title":"Arthritis Rheum."},{"key":"1730_CR238","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.4049\/jimmunol.1301373","volume":"192","author":"S Yao","year":"2014","unstructured":"Yao, S. et al. CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3\u2212 lymphocytes: mechanisms of CD4+ T cell immunity. J. Immunol. 192, 2120\u20132132 (2014).","journal-title":"J. Immunol."},{"key":"1730_CR239","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230707","volume":"220","author":"CG Winchell","year":"2023","unstructured":"Winchell, C. G. et al. CD8+ lymphocytes are critical for early control of tuberculosis in macaques. J. Exp. Med. 220, e20230707 (2023).","journal-title":"J. Exp. Med."},{"key":"1730_CR240","doi-asserted-by":"publisher","first-page":"773","DOI":"10.4049\/jimmunol.1300113","volume":"191","author":"JT Mattila","year":"2013","unstructured":"Mattila, J. T. et al. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J. Immunol. 191, 773\u2013784 (2013).","journal-title":"J. Immunol."},{"key":"1730_CR241","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/infdis\/jis778","volume":"207","author":"S Mehra","year":"2013","unstructured":"Mehra, S. et al. Granuloma correlates of protection against tuberculosis and mechanisms of immune modulation by Mycobacterium tuberculosis. J. Infect. Dis. 207, 1115\u20131127 (2013).","journal-title":"J. Infect. Dis."},{"key":"1730_CR242","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.163101","volume":"8","author":"B Singh","year":"2023","unstructured":"Singh, B. et al. Inhibition of indoleamine dioxygenase leads to better control of tuberculosis adjunctive to chemotherapy. JCI Insight 8, e163101 (2023).","journal-title":"JCI Insight"},{"key":"1730_CR243","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41577-018-0025-3","volume":"18","author":"JD Simmons","year":"2018","unstructured":"Simmons, J. D. et al. Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat. Rev. Immunol. 18, 575\u2013589 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1730_CR244","first-page":"1342","volume":"221","author":"AJ Verrall","year":"2020","unstructured":"Verrall, A. J. et al. Early clearance of Mycobacterium tuberculosis is associated with increased innate immune responses. J. Infect. Dis. 221, 1342\u20131350 (2020).","journal-title":"J. Infect. Dis."},{"key":"1730_CR245","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.xcrm.2020.100185","volume":"2","author":"MPM Vierboom","year":"2021","unstructured":"Vierboom, M. P. M. et al. Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination. Cell Rep. Med. 2, 100185 (2021).","journal-title":"Cell Rep. Med."},{"key":"1730_CR246","doi-asserted-by":"publisher","first-page":"514682","DOI":"10.3389\/fmicb.2020.01339","volume":"11","author":"N Aguilo","year":"2020","unstructured":"Aguilo, N. et al. Respiratory immunization with a whole cell inactivated vaccine induces functional mucosal immunoglobulins against tuberculosis in mice and non-human primates. Front. Microbiol. 11, 514682 (2020).","journal-title":"Front. Microbiol."},{"key":"1730_CR247","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.chom.2020.11.013","volume":"29","author":"E Esaulova","year":"2021","unstructured":"Esaulova, E. et al. The immune landscape in tuberculosis reveals populations linked to disease and latency. Cell Host Microbe 29, 165\u2013178 (2021).","journal-title":"Cell Host Microbe"},{"key":"1730_CR248","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.3390\/cells12182295","volume":"12","author":"S Kulkarni","year":"2023","unstructured":"Kulkarni, S., Endsley, J. J., Lai, Z., Bradley, T. & Sharan, R. Single-cell transcriptomics of Mtb\/HIV co-infection. Cells 12, 2295 (2023).","journal-title":"Cells"},{"key":"1730_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102686","volume":"53","author":"Y Cai","year":"2020","unstructured":"Cai, Y. et al. Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis. eBioMedicine 53, 102686 (2020).","journal-title":"eBioMedicine"},{"key":"1730_CR250","doi-asserted-by":"publisher","first-page":"110983","DOI":"10.1016\/j.celrep.2022.110983","volume":"39","author":"S Akter","year":"2022","unstructured":"Akter, S. et al. Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes. Cell Rep. 39, 110983 (2022).","journal-title":"Cell Rep."},{"key":"1730_CR251","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.tim.2020.03.015","volume":"28","author":"R Sharan","year":"2020","unstructured":"Sharan, R. et al. Chronic immune activation in TB\/HIV co-infection. Trends Microbiol. 28, 619\u2013632 (2020).","journal-title":"Trends Microbiol."},{"key":"1730_CR252","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00558-22","volume":"91","author":"EC Larson","year":"2023","unstructured":"Larson, E. C. et al. Host immunity to Mycobacterium tuberculosis infection is similar in simian immunodeficiency virus (SIV)-infected, antiretroviral therapy-treated and SIV-na\u00efve juvenile macaques. Infect. Immun. 91, e0055822 (2023).","journal-title":"Infect. Immun."},{"key":"1730_CR253","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fimmu.2020.00303","volume":"11","author":"CN Ratnatunga","year":"2020","unstructured":"Ratnatunga, C. N. et al. The rise of non-tuberculosis mycobacterial lung disease. Front. Immunol. 11, 303 (2020).","journal-title":"Front. Immunol."},{"key":"1730_CR254","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.4049\/jimmunol.162.11.6734","volume":"162","author":"MS Gomes","year":"1999","unstructured":"Gomes, M. S., Fl\u00f3rido, M., Pais, T. F. & Appelberg, R. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J. Immunol. 162, 6734\u20136739 (1999).","journal-title":"J. Immunol."},{"key":"1730_CR255","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/ijms23010269","volume":"23","author":"AC Moreira","year":"2021","unstructured":"Moreira, A. C. et al. H-ferritin produced by myeloid cells is released to the circulation and plays a major role in liver iron distribution during infection. Int. J. Mol. Sci. 23, 269 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1730_CR256","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.4049\/jimmunol.1900382","volume":"203","author":"AC Gomes","year":"2019","unstructured":"Gomes, A. C. et al. IFN-\u03b3\u2013dependent reduction of erythrocyte life span leads to anemia during mycobacterial infection. J. Immunol. 203, 2485\u20132496 (2019).","journal-title":"J. Immunol."},{"key":"1730_CR257","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60452-1","volume":"10","author":"EC Maggioncalda","year":"2020","unstructured":"Maggioncalda, E. C. et al. A mouse model of pulmonary Mycobacteroides abscessus infection. Sci. Rep. 10, 3690 (2020).","journal-title":"Sci. Rep."},{"key":"1730_CR258","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28638-5","volume":"13","author":"JY Kam","year":"2022","unstructured":"Kam, J. Y. et al. Rough and smooth variants of Mycobacterium abscessus are differentially controlled by host immunity during chronic infection of adult zebrafish. Nat. Commun. 13, 952 (2022).","journal-title":"Nat. Commun."},{"key":"1730_CR259","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fcimb.2020.00357","volume":"10","author":"MD Johansen","year":"2020","unstructured":"Johansen, M. D. & Kremer, L. CFTR depletion confers hypersusceptibility to Mycobacterium fortuitum in a zebrafish model. Front. Cell. Infect. Microbiol. 10, 357 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1730_CR260","doi-asserted-by":"publisher","first-page":"718477","DOI":"10.3389\/fmicb.2021.718477","volume":"12","author":"VO Mussi","year":"2021","unstructured":"Mussi, V. O. et al. A murine model of Mycobacterium kansasii infection reproducing necrotic lung pathology reveals considerable heterogeneity in virulence of clinical isolates. Front. Microbiol. 12, 718477 (2021).","journal-title":"Front. Microbiol."},{"key":"1730_CR261","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/pathogens9080641","volume":"9","author":"E Rampacci","year":"2020","unstructured":"Rampacci, E., Stefanetti, V., Passamonti, F. & Henao-Tamayo, M. Preclinical models of nontuberculous mycobacteria infection for early drug discovery and vaccine research. Pathogens 9, 641 (2020).","journal-title":"Pathogens"}],"container-title":["Lab Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01730-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01730-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01730-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:01:06Z","timestamp":1782856866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41684-026-01730-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":261,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1038\/s41684-026-01730-9","relation":{},"ISSN":["0093-7355","1548-4475"],"issn-type":[{"value":"0093-7355","type":"print"},{"value":"1548-4475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}